within Pharmacolibrary.Drugs.ATC.A;

model A10BX05
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 120 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 5e-05,
    k12             = 1.6,
    k21             = 1.6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10BX05</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Pramlintide is a synthetic analogue of human amylin, a peptide hormone co-secreted with insulin by pancreatic beta cells. It is used as an adjunct to insulin therapy for the treatment of type 1 and type 2 diabetes mellitus to control postprandial blood glucose levels. Pramlintide is currently approved and marketed for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy volunteers and diabetic patients; data typically derived from subcutaneous administration.</p><h4>References</h4><ol><li><p>Furió-Novejarque, C, et al., &amp; Bondia, J (2024). A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data. <i>Computer methods and programs in biomedicine</i> 244 107968–None. DOI:<a href=\"https://doi.org/10.1016/j.cmpb.2023.107968\">10.1016/j.cmpb.2023.107968</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38064957/\">https://pubmed.ncbi.nlm.nih.gov/38064957</a></p></li><li><p>Russell-Jones, D, &amp; Khan, R (2007). Insulin-associated weight gain in diabetes--causes, effects and coping strategies. <i>Diabetes, obesity &amp; metabolism</i> 9(6) 799–812. DOI:<a href=\"https://doi.org/10.1111/j.1463-1326.2006.00686.x\">10.1111/j.1463-1326.2006.00686.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17924864/\">https://pubmed.ncbi.nlm.nih.gov/17924864</a></p></li><li><p>McQueen, J (2005). Pramlintide acetate. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 62(22) 2363–2372. DOI:<a href=\"https://doi.org/10.2146/ajhp050341\">10.2146/ajhp050341</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16278328/\">https://pubmed.ncbi.nlm.nih.gov/16278328</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10BX05;
